Product Code: ETC7536783 | Publication Date: Sep 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India antiparasitic drugs market import shipments displayed robust growth with a CAGR of 10.7% from 2020 to 2024. The momentum further accelerated, showing a significant growth rate of 67.5% between 2023 and 2024. The market clearly expanded rapidly over the years, indicating a strong upward trend.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antiparasitic Drugs Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antiparasitic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 India Antiparasitic Drugs Market - Industry Life Cycle |
3.4 India Antiparasitic Drugs Market - Porter's Five Forces |
3.5 India Antiparasitic Drugs Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 India Antiparasitic Drugs Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 India Antiparasitic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of parasitic infections in India |
4.2.2 Growing awareness about the importance of antiparasitic drugs for public health |
4.2.3 Rising investments in healthcare infrastructure and research development in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 High competition from generic drug manufacturers leading to pricing pressures |
4.3.2 Limited access to healthcare services in rural areas hindering the reach of antiparasitic drugs |
4.3.3 Regulatory hurdles and approval processes affecting the market entry of new antiparasitic drugs |
5 India Antiparasitic Drugs Market Trends |
6 India Antiparasitic Drugs Market, By Types |
6.1 India Antiparasitic Drugs Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 India Antiparasitic Drugs Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 India Antiparasitic Drugs Market Revenues & Volume, By HIV, 2021- 2031F |
6.1.4 India Antiparasitic Drugs Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.1.5 India Antiparasitic Drugs Market Revenues & Volume, By Influenza, 2021- 2031F |
6.1.6 India Antiparasitic Drugs Market Revenues & Volume, By TB, 2021- 2031F |
6.1.7 India Antiparasitic Drugs Market Revenues & Volume, By Malaria, 2021- 2031F |
6.1.8 India Antiparasitic Drugs Market Revenues & Volume, By HPV, 2021- 2031F |
6.2 India Antiparasitic Drugs Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 India Antiparasitic Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 India Antiparasitic Drugs Market Revenues & Volume, By Clinics, 2021- 2031F |
6.2.4 India Antiparasitic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 India Antiparasitic Drugs Market Import-Export Trade Statistics |
7.1 India Antiparasitic Drugs Market Export to Major Countries |
7.2 India Antiparasitic Drugs Market Imports from Major Countries |
8 India Antiparasitic Drugs Market Key Performance Indicators |
8.1 Number of healthcare facilities offering antiparasitic treatments |
8.2 Percentage of the population covered under government healthcare schemes for parasitic infections |
8.3 Research and development expenditure on innovative antiparasitic drug formulations |
9 India Antiparasitic Drugs Market - Opportunity Assessment |
9.1 India Antiparasitic Drugs Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 India Antiparasitic Drugs Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 India Antiparasitic Drugs Market - Competitive Landscape |
10.1 India Antiparasitic Drugs Market Revenue Share, By Companies, 2024 |
10.2 India Antiparasitic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |